Drug: CLONIDINE TRANSDERMAL SYSTEM Injury: Application site erythema Quarter: 2016Q3
Total Records: 7 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
126770331 | CLONIDINE TRANSDERMAL SYSTEM | Application site erythema | MYLAN | 80.75 YR | F | 59 KG | 20160823 | US |
126770341 | CLONIDINE TRANSDERMAL SYSTEM | Application site erythema | MYLAN | 0.00 | M | 85 KG | 20160823 | US |
126770411 | CLONIDINE TRANSDERMAL SYSTEM | Application site erythema | MYLAN | 0.00 | F | 0 | 20160823 | US |
126770731 | CLONIDINE TRANSDERMAL SYSTEM | Application site erythema | MYLAN | 12.00 YR | M | 0 | 20160823 | US |
126770781 | CLONIDINE TRANSDERMAL SYSTEM | Application site erythema | MYLAN | 88.00 YR | F | 0 | 20160823 | US |
126770791 | CLONIDINE TRANSDERMAL SYSTEM | Application site erythema | MYLAN | 8.90 YR | M | 0 | 20160823 | US |
126770881 | CLONIDINE TRANSDERMAL SYSTEM | Application site erythema | MYLAN | 65.04 YR | F | 54 KG | 20160823 | US |
Total Records: 7 Number of Pages: 1